Does LANADELUMAB Cause Product use issue? 229 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 229 reports of Product use issue have been filed in association with LANADELUMAB (TAKHZYRO). This represents 11.1% of all adverse event reports for LANADELUMAB.
229
Reports of Product use issue with LANADELUMAB
11.1%
of all LANADELUMAB reports
3
Deaths
129
Hospitalizations
How Dangerous Is Product use issue From LANADELUMAB?
Of the 229 reports, 3 (1.3%) resulted in death, 129 (56.3%) required hospitalization, and 4 (1.7%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANADELUMAB. However, 229 reports have been filed with the FAERS database.
What Other Side Effects Does LANADELUMAB Cause?
Hereditary angioedema (1,343)
Product dose omission issue (555)
Weight decreased (361)
Weight increased (353)
Inappropriate schedule of product administration (318)
Covid-19 (225)
Injection site pain (201)
Insurance issue (172)
Drug ineffective (142)
Stress (137)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which LANADELUMAB Alternatives Have Lower Product use issue Risk?
LANADELUMAB vs LANADELUMAB-FLYO
LANADELUMAB vs LANREOTIDE
LANADELUMAB vs LANSOPRAZOLE
LANADELUMAB vs LANTHANUM
LANADELUMAB vs LANTUS